Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Next-generation Sequencing: Slowly Moving towards the $1,000 Genome

This article was originally published in Start Up

Executive Summary

Even if most attempts to read DNA strands in real time appear stalled and the goal of true single-molecule sequencing has, with the notable exception of Helicos, for the most part given way (at least for the time being) in favor of cluster-based approaches with lower data densities, there's still plenty of opportunity for start-ups to advance the field of next-generation sequencing: with microfluidics, nanotechnology, and biochemistries to better enable direct DNA observation and analysis.
Advertisement

Related Content

The How And When Of Applying Sequencing To Clinical Diagnostics
GnuBio: Whole Genome Sequencing for $30
Financings Of The Fortnight: Cardiome's Reticence The Exception During Busy Spate Of Deals
Illumina Goes Consumer
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2008
Can Nanotech Be a Game-Changer for In Vitro Diagnostics?
Deal Statistics Quarterly, Q1 2007
Microchip Biotechnologies Inc.
BioNanomatrix LLC
LaserGen Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC091206

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel